The molecular diagnostic laboratory provides quantitative polymerase chain reaction (PCR), mutation analysis and gene sequencing to support therapy selection, treatment monitoring and minimal residual disease detection with a complete range of clinically actionable tests; Provided as part of MPLN's evidence based comprehensive strategic reflex testing protocol or can be ordered individually. Molecular Diagnostics Flyer (DEC2018)
A-Z Molecular Diagnostic Oncology Tests
B-cell IGH Gene Rearrangement by Next Generation Sequencing
BCR/ABL qRT PCR, Major p210 and Minor p190 Mutations, Minimal Residual Disease
BRAF Mutation Analysis by Next Generation Sequencing
Chlamydia Trachomatis (CT), Qualitative by Aptima COMBO® 2 TMA
Colon Cancer Panel by Next Generation Sequencing
EGFR Mutation Analysis by Next Generation Sequencing
Herpes Simplex Virus (HSV) Type 1 and 2 Qualitative by PCR
Human Papillomavirus (HPV) Genotyping
Human Papillomavirus (HPV) High Risk by Aptima HPV
IgVH Somatic Hypermutation by Next Generation Sequencing
JAK2 V617F Mutation Analysis by PCR
KRAS Mutation Analysis by Next Generation Sequencing
MYD88 p.L265P Mutation Analysis by Next Generation Sequencing
← prev 2 next →